Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 643-648

  Laclaustra, Martin ^a,b   Stranges, Saverio ^c   Navas Acien, Ana ^b,d   Ordovas, Jose M ^a,e   Guallar, Eliseo ^a,b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

NHANES; Selenium; Serum lipids

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; HEALTH SURVEY; HUMAN; LIPID BLOOD LEVEL; MALE; MASS SPECTROMETRY; METABOLISM; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LIPIDS; MALE; MIDDLE AGED; NUTRITION SURVEYS; NUTRITIONAL STATUS; SELENIUM; UNITED STATES;

EID: 77953229083     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.005     Document Type: Article

References (30)

1. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356(9225):233-241.
2. Institute of Medicine (U.S.) Panel on dietary antioxidants and related compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine 2000, National Academy Press, Washington, DC.
3. Bleys J., Navas-Acien A., Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007, 30(4):829-834.
4. Laclaustra M., Navas-Acien A., Stranges S., Ordovas J.M., Guallar E. Serum selenium concentrations and diabetes in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 2009, 117:1409-1413.
5. Laclaustra M., Navas-Acien A., Stranges S., Ordovas J.M., Guallar E. Serum selenium concentrations and hypertension in the US population. Circ Cardiovasc Qual Outcomes 2009, 2:369-376.
6. Stranges S., Marshall J.R., Trevisan M., et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 2006, 163(8):694-699.
7. Stranges S., Marshall J.R., Natarajan R., et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147(4):217-223.
8. Lippman S.M., Klein E.A., Goodman P.J., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301(1):39-51.
9. Bleys J., Navas-Acien A., Stranges S., Menke A., Miller E.R., Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr 2008, 88(2):416-423.
10. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. Hyattsville, MD: U.S.: Department of Health and Human Services, Centers for Disease Control and Prevention, 2003-2004. Reprint: [accessed 9 September 2008]. http://www.cdc.gov/nchs/nhanes.htm.
11. Tobin M.D., Sheehan N.A., Scurrah K.J., Burton P.R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005, 24(19):2911-2935.
12. Coudray C., Roussel A.M., Mainard F., Arnaud J., Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr 1997, 16(6):584-591.
13. Stranges S., Laclaustra M., Ji C., Cappuccio F.P., Navas-Acien A., Ordovas J.M., Rayman M., Guallar E. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 2010, 140(1):81-87.
14. Ringstad J., Jacobsen B.K., Thomassen Y. The Tromso Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease. J Trace Elem Electrolytes Health Dis 1987, 1(1):27-31.
15. Jossa F., Trevisan M., Krogh V., et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991, 87(2-3):129-134.
16. Suadicani P., Hein H.O., Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992, 96(1):33-42.
17. Hercberg S., Bertrais S., Czernichow S., et al. Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study. Lipids 2005, 40(4):335-342.
18. Zhang L., Gail M.H., Wang Y.Q., et al. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr 2006, 84(4):912-919.
19. Luoma P.V., Sotaniemi E.A., Korpela H., Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol-effect of selenium supplementation. Res Commun Chem Pathol Pharmacol 1984, 46(3):469-472.
20. Yu S.Y., Mao B.L., Xiao P., et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study. Biol Trace Elem Res 1990, 24(2):105-108.
21. Ducros V., Laporte F., Belin N., David A., Favier A. Selenium determination in human plasma lipoprotein fractions by mass spectrometry analysis. J Inorg Biochem 2000, 81(1-2):105-109.
22. Burk R.F. Invivo Se-75 binding to human plasma-proteins after administration of Se-75 O3 2-Biochim Biophys Acta 1974, 372(2):255-265.
23. Burk R.F., Hill K.E. Selenoprotein P-Expression, functions, and roles in mammals. Biochim Biophys Acta 2009, 1790(11):1441-1447.
24. Olson G.E., Winfrey V.P., Hill K.E., Burk R.F. Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J Biol Chem 2008, 283(11):6854-6860.
25. Sengupta A., Carlson B.A., Hoffmann V.J., Gladyshev V.N., Hatfield D.L. Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem Biophys Res Commun 2008, 365(3):446-452.
26. Moosmann B., Behl C. Selenoprotein synthesis and side-effects of statins. Lancet 2004, 363(9412):892-894.
27. Arnaud J., Akbaraly T.N., Hininger-Favier I., Berr C., Roussel A.M. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients-the EVA study. J Trace Elem Med Biol 2009, 23(1):21-28.
28. Whanger P., Vendeland S., Park Y.C., Xia Y. Metabolism of subtoxic levels of selenium in animals and humans. Ann Clin Lab Sci 1996, 26(2):99-113.
29. Vinceti M., Wei E.T., Malagoli C., Bergomi M., Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health 2001, 16(4):233-251.
30. Rayman M.P. Food-chain selenium and human health: emphasis on intake. Br J Nutr 2008, 100(2):254-268.